Body Fat Depots Explained: Why Where You Store Fat Matters More Than How Much

Why BMI Misses the Point

BMI relates weight to height. It tells you nothing about where that weight is stored or what type of tissue it represents.

A lean athlete with high muscle mass, low visceral fat, and healthy brown fat deposits may have a higher BMI than a sedentary person with low muscle mass but significant visceral and ectopic fat accumulation. The athlete has the better metabolic health by every meaningful measure — and the lower disease risk. BMI assigns them higher numerical risk.

Conversely, some people with a BMI in the "normal" range carry significant visceral and ectopic fat. Research on this "metabolically obese, normal weight" phenotype shows disease risk comparable to people with clinically defined obesity when visceral and ectopic fat are high. This is the most important practical insight from adipose depot biology.

Waist circumference — as a proxy for abdominal adiposity — is a better predictor of metabolic risk than BMI. Current clinical guidelines recommend a waist circumference below 80cm for women and 94cm for men as the lower risk threshold. Waist-to-height ratio — dividing waist circumference by height — is increasingly recognised as the most practically useful single measurement for cardiometabolic risk assessment.

Subcutaneous Fat: The Protective Depot

Subcutaneous fat sits beneath the skin — around the hips, thighs, buttocks, upper arms, and the layer just under facial skin. It accounts for approximately 85% of total body fat in most people across a wide range of body compositions.

Subcutaneous white adipose tissue has important beneficial characteristics including storage of lipid out of harm's way and secretion of adipokines, especially leptin and adiponectin, with positive metabolic effects including lipid oxidation, energy utilisation, enhanced insulin action, and an anti-inflammatory role. — London Now

The key concept here is "storage of lipid out of harm's way." Subcutaneous fat's primary metabolic function is to safely sequester energy that would otherwise spill over into more dangerous locations. People with a high capacity to store fat subcutaneously — typically those with a "pear-shaped" body composition — are protected against ectopic fat accumulation in the liver and muscle, even when total fat mass is high.

This partly explains why hip and thigh fat, despite being associated with higher overall weight, is consistently associated with lower cardiometabolic risk than abdominal fat. The hip-to-waist ratio captures this — higher hip-to-waist ratios, reflecting more subcutaneous and less visceral fat, are associated with better metabolic health outcomes.

Subcutaneous white adipose tissue may retain protective features in early obesity — acting as a metabolic buffer that limits spillover into visceral and ectopic depots. This protection breaks down as subcutaneous capacity is exceeded, which is when visceral and ectopic accumulation accelerates.

Subcutaneous fat does become problematic at very high quantities — particularly the deep subcutaneous layer closest to the abdominal cavity, which behaves more like visceral fat than peripheral subcutaneous fat in its inflammatory properties. But the general principle holds: subcutaneous fat is the least dangerous place for the body to store excess energy.

Visceral Fat: The High-Risk Depot

Visceral fat sits deep within the abdomen, surrounding and infiltrating the liver, pancreas, intestines, and other abdominal organs. It accounts for a relatively small proportion of total body fat — typically 10 to 20% — but has disproportionate effects on metabolic health.

Visceral white adipose tissue emerges as a critical site of inflammation and metabolic inflexibility. Several properties make it uniquely problematic:

Direct hepatic drainage — visceral fat's venous drainage flows directly into the portal vein, which carries blood to the liver. This means that free fatty acids and inflammatory mediators released by visceral fat are delivered to the liver at high concentrations, driving hepatic fat accumulation, insulin resistance, and dyslipidaemia.

High lipolytic activity — visceral fat releases free fatty acids at a higher rate than subcutaneous fat, contributing to elevated circulating lipids and liver fat.

Inflammatory signalling — visceral fat releases pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β at significantly higher rates than subcutaneous fat. This chronic low-grade inflammation is a primary driver of insulin resistance, endothelial dysfunction, and cardiovascular risk.

Adipokine dysregulation — visceral fat produces less adiponectin (an anti-inflammatory, insulin-sensitising hormone) and more leptin, resistin, and visfatin, shifting the hormonal environment toward metabolic dysfunction.

High visceral fat is strongly associated with type 2 diabetes, cardiovascular disease, MASLD (fatty liver disease), sleep apnoea, and certain cancers. The good news is that visceral fat is also the most responsive to lifestyle intervention — it reduces more rapidly with exercise, dietary improvement, and sleep optimisation than subcutaneous fat does, often producing significant metabolic improvement even before visible weight change.

Ectopic Fat: The Most Harmful Pattern

Ectopic fat is fat stored in organs not anatomically designed for fat storage — primarily the liver, skeletal muscle, pancreas, and heart. It develops when the body's fat storage capacity in subcutaneous depots is exceeded and fat begins accumulating in functional tissue.

Ectopic tissue lipid, together with visceral white adipose tissue, is potentially harmful and represents the most dangerous fat accumulation pattern from a metabolic health perspective. — London Now

Liver fat (hepatic steatosis) — the foundation of MASLD, discussed in detail in our separate article on that condition. See Understanding MASLD — and How to Support a Healthier Liver. Even small amounts of liver fat produce measurable insulin resistance and disrupt lipid metabolism.

Muscle fat (intramyocellular lipid) — fat within skeletal muscle fibres directly impairs insulin signalling in muscle cells, reducing glucose uptake and worsening systemic insulin resistance. High intramyocellular lipid is found even in lean people who are physically inactive.

Pancreatic fat — fat accumulation in the pancreas impairs beta cell function, reducing insulin secretion capacity. This is increasingly recognised as a contributor to type 2 diabetes development independent of total body fat.

Pericardial and epicardial fat — fat surrounding the heart has direct inflammatory effects on cardiac tissue and is associated with atrial fibrillation and coronary artery disease.

The critical clinical implication: ectopic fat can be present in lean individuals who have never been obese. People with a genetic or lifestyle tendency toward visceral and ectopic fat accumulation — sometimes called the "lipodystrophic" phenotype — can have significant metabolic disease at normal body weight. They are systematically missed by BMI-based screening.

Brown Fat: The Beneficial Depot

This is the most actively researched and arguably most exciting area of adipose biology — and it is almost entirely absent from mainstream wellness conversation.

Adipose tissue is a dynamic metabolic organ that plays a central role in energy homeostasis, endocrine signalling, and thermoregulation. Brown adipose tissue differs both structurally and functionally from white adipose tissue. — Cotswold & Evesham Journal

White fat stores energy. Brown fat burns it. Brown adipose tissue (BAT) is densely packed with mitochondria and expresses high levels of uncoupling protein 1 (UCP1), which allows it to generate heat by burning fatty acids rather than converting them to ATP. This thermogenic activity gives brown fat its distinctive dark colour — the colour of mitochondria-rich, highly vascularised tissue.

Brown adipose tissue is associated with lower amounts of visceral adipose tissue and higher amounts of subcutaneous adipose tissue, resulting in less central obesity. In addition, BAT is independently associated with lower blood glucose and white blood cell count, improved lipids, lower prevalence of type 2 diabetes mellitus, and decreased liver fat accumulation. These observations are most prominent in individuals with central obesity. — O8

Adults have far less brown fat than infants — it was long believed that adults had essentially none. Advanced PET-CT imaging has since demonstrated meaningful brown fat deposits in adults, primarily in the supraclavicular region, neck, and paravertebral area. The amount varies considerably between individuals and is significantly influenced by lifestyle factors.

Cold exposure is the most powerful known activator of brown fat — it directly stimulates thermogenesis through UCP1. This is part of the physiological basis for cold water immersion's metabolic benefits. Regular exercise also increases brown fat activity and promotes "browning" — the conversion of white adipocytes to beige adipocytes, which share some of brown fat's thermogenic properties.

The endocrine roles of adipokines and batokines — signalling molecules specifically released by brown adipose tissue — are increasingly understood to have systemic effects on metabolism, including improving insulin sensitivity and reducing visceral fat accumulation.

Beige Fat: The Trainable Depot

Beige (or brite) fat is a hybrid adipose type that can be induced to behave like brown fat under specific conditions. White adipocytes can be "browned" — induced to express UCP1 and adopt thermogenic properties — through cold exposure, exercise, and certain dietary compounds.

Brown or beige fat expansion can enhance thermogenesis, lipid oxidation, insulin sensitivity, and glucose tolerance. — London Now

The practical implication: the amount of metabolically beneficial thermogenic fat you have is not fixed. Exercise, cold exposure, and dietary factors can shift the balance of adipose tissue toward more metabolically beneficial types. This is an active area of therapeutic research and explains interest in cold exposure protocols and exercise prescriptions that specifically target metabolic rather than aesthetic outcomes.

Epiploic Fat: Clinically Minor, Often Confused

Epiploic fat appendages are small pouches of fat attached to the outer surface of the colon. Under normal conditions they are anatomically localised, metabolically quiet, and entirely without systemic health significance.

They become clinically relevant only when inflamed — a condition called epiploic appendagitis, which causes acute, localised abdominal pain that can mimic appendicitis or diverticulitis. It is self-limiting in the vast majority of cases, resolves with anti-inflammatory medication, and is not associated with metabolic risk, obesity, or visceral fat accumulation.

Epiploic appendagitis is worth knowing about because it is not uncommon — it accounts for a meaningful proportion of presentations with acute abdominal pain — and because it is frequently misdiagnosed. But it is not part of the metabolic fat story.

What Drives Visceral and Ectopic Fat Accumulation

The same factors that drive MASLD drive harmful fat accumulation more broadly:

Chronic stress and cortisol elevation — cortisol specifically promotes visceral fat deposition. The well-documented relationship between chronic stress and abdominal weight gain operates through this mechanism. See Cortisol Explained — and How to Reduce It Without Making Things Worse for a deeper look at the mechanism. Cortisol also promotes gluconeogenesis and lipolysis in ways that raise circulating fatty acids and liver fat.

Sleep disruption — poor sleep raises cortisol, worsens insulin sensitivity, and alters adipose tissue gene expression in ways that favour visceral over subcutaneous accumulation. Even two nights of poor sleep produce measurable changes in fat distribution markers.

Physical inactivity — low physical activity, particularly low muscle mass and sedentary time, reduces the body's capacity to clear glucose and fatty acids from circulation. Visceral and ectopic fat accumulate preferentially when metabolic clearance is impaired.

Ultra-processed food and fructose — high dietary fructose specifically promotes visceral fat and liver fat accumulation through its effects on hepatic de novo lipogenesis. Ultra-processed foods — engineered for palatability and energy density — consistently produce visceral fat accumulation in controlled feeding studies.

Alcohol — alcohol is metabolised in the liver and produces acetate, which competes with fatty acid oxidation, promoting hepatic fat accumulation and contributing to ectopic fat more broadly.

What Actually Reduces Visceral and Ectopic Fat

Exercise is the most evidence-backed intervention for visceral fat reduction — specifically aerobic exercise. Meta-analyses consistently show that aerobic exercise reduces visceral fat significantly, even without weight loss, through improvements in insulin sensitivity and fatty acid oxidation. Resistance training reduces intramyocellular fat and improves muscle-based glucose disposal.

Dietary quality improvement — reducing ultra-processed food, fructose, refined carbohydrates, and excess saturated fat produces rapid reductions in liver fat and visceral fat, often before significant weight loss occurs. Lower-carbohydrate approaches can help certain phenotypes — see The Keto Diet: Who It Actually Works For — and Who It Doesn't.

Sleep optimisation — consistent, adequate sleep (seven to nine hours at consistent times) reduces cortisol-driven visceral fat accumulation and improves insulin sensitivity.

Stress management — any sustained reduction in chronic cortisol load reduces visceral fat accumulation. Exercise, mindfulness, social connection, and nature exposure all have evidence for cortisol reduction.

Cold exposure — activates brown fat thermogenesis, promotes beige fat development, and has emerging evidence for visceral fat reduction through these mechanisms. Cold showers and cold water immersion both show effects in the research, with the mechanism involving direct sympathetic nervous system activation of brown adipose tissue.

Frequently Asked Questions

Is visceral fat the same as belly fat?

Not exactly. Belly fat refers to all fat in the abdominal region — including the subcutaneous fat you can pinch under the skin. Visceral fat sits deeper, surrounding the organs, and cannot be felt from outside. It is the visceral component of abdominal fat that drives metabolic risk, not the subcutaneous layer. Waist circumference captures both, which is why it correlates with risk — but the subcutaneous component is considerably less dangerous than the visceral component.

Can you be a healthy weight and have too much visceral fat?

Yes — this is the "metabolically obese, normal weight" phenotype. People with low muscle mass, sedentary habits, poor diet quality, and a genetic tendency toward central fat distribution can have significant visceral and ectopic fat at a normal BMI. They face metabolic disease risk comparable to people with clinical obesity and are systematically missed by BMI-based screening. Waist circumference and fasting metabolic markers are more useful screening tools for this group.

Does spot reduction work — can you target fat loss in a specific area?

No. Spot reduction — the idea that exercising a specific body part reduces fat in that area — is not supported by evidence. Fat is mobilised systemically in response to energy deficit, with the pattern of loss determined by genetics, hormones, and fat depot characteristics. However, visceral fat responds more rapidly to lifestyle intervention than subcutaneous fat, which means that metabolic improvement often precedes visible changes in body composition.

What is brown fat and how do I increase it?

Brown adipose tissue is a thermogenic fat type that burns energy rather than storing it. Adults have small amounts, primarily in the neck and supraclavicular region. Cold exposure is the most powerful known activator — regular cold showers or cold water immersion stimulates brown fat thermogenesis. Exercise promotes both brown fat activity and the development of beige fat — metabolically similar white fat that has been converted to a thermogenic phenotype. People with more brown fat have consistently better metabolic markers including lower visceral fat and reduced diabetes risk.

How do I know if I have too much visceral fat?

The most accessible proxy is waist circumference — above 80cm for women and 94cm for men indicates elevated visceral fat risk. Waist-to-height ratio above 0.5 is a useful population-level indicator. Clinically, a DEXA scan can quantify visceral fat directly. Metabolic markers on a standard blood test — elevated fasting triglycerides, low HDL cholesterol, elevated fasting glucose, elevated ALT — are indirect indicators of visceral and ectopic fat burden.

What is the fastest way to reduce visceral fat?

Aerobic exercise and dietary quality improvement produce the most rapid visceral fat reduction, often before significant weight loss occurs. A combination of reduced ultra-processed food and fructose, increased fibre, aerobic exercise five days per week, adequate sleep, and stress management produces meaningful changes in visceral fat within eight to twelve weeks in most people. These interventions work through improving insulin sensitivity and reducing the cortisol-driven and dietary drivers of visceral fat accumulation simultaneously.

The Bottom Line

Body fat is not a uniform substance and the question of how much you have matters considerably less than where it is stored. Visceral and ectopic fat are the metabolically dangerous depots — driving insulin resistance, inflammation, and cardiovascular risk in ways that subcutaneous fat does not. Brown and beige fat are beneficial and can be increased through lifestyle. Subcutaneous fat is largely protective.

The practical takeaway: waist circumference is a more meaningful health indicator than weight or BMI. Exercise, sleep, stress management, and dietary quality specifically target the most dangerous fat depots — often producing significant metabolic improvement before the scale moves.

For structured support addressing the lifestyle factors that drive visceral and ectopic fat accumulation, the Gut Reset, Stress Reset and Sleep Reset from the Reset Series™ address the interconnected drivers most directly linked to harmful fat distribution. Pair any of them with the Reset Companion for personalised, in-context guidance as you work through the protocol.

Related reading: Understanding MASLD — and How to Support a Healthier Liver · Cortisol Explained — and How to Reduce It Without Making Things Worse · The Keto Diet: Who It Actually Works For — and Who It Doesn't

Popular Articles